(Q44253289)

1 December 2017

Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health (English)

1 reference

1 December 2017

2

Michael Camilleri

1 reference

1 December 2017

Heather J Chial

1

1 reference

1 December 2017

Duane Burton

3

1 reference

1 December 2017

George Thomforde

4

1 reference

1 December 2017

Kevin W Olden

5

1 reference

1 December 2017

Debra Stephens

6

1 reference

1 December 2017

1 January 2003

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

1 December 2017

1 reference

1 December 2017

284

1 reference

1 December 2017

1

1 reference

1 December 2017

G130-7

1 reference

Towards a less costly but accurate test of gastric emptying and small bowel transit

1 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00266.2002

A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00266.2002

Antidepressants for functional gastrointestinal syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00266.2002

Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and Vomiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00266.2002

5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00266.2002

Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00266.2002

Development of a test to measure gastric accommodation in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00266.2002

Effects of 5-HT(3) antagonism on postprandial gastric volume and symptoms in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00266.2002

Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00266.2002

Buspirone inhibits corticotropin-releasing factor and stress-induced cecal motor response in rats by acung through 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00266.2002

Responses to gastric distension in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00266.2002

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00266.2002

Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00266.2002

Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00266.2002

Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00266.2002

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00266.2002

1 reference

1 December 2017

1 reference